microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition
microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition is a paper indexed in ScholarIQ from OpenAlex.
How many citations does microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition have?
microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition has 23 citations in the OpenAlex counts ScholarIQ stores.
When was microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition published?
microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition has 2022 year in the ScholarIQ index.
What is the open-access status of microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition?
microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition has gold oa status in the ScholarIQ index.
What is the DOI of microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition?
The DOI for microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition is on the source record.
What is the PMID of microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition?
The PMID for microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition is on the source record.
What is the OpenAlex record for microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition?
The OpenAlex for microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition is on the source record.